NEW YORK (AP) — Mylan says it will make available a generic version of its EpiPen, as criticism continued to mount over the price of its injectable medicine.adcelannotate = {"mobilepaywallcategory" : "MOBILE_PREM-BUSINESS","nativepaywallcategory" : "NATIVE_PREM-BUSINESS"};